SUMMARY Twenty-one patients treated for depression with iprindole developed evidence of liver damage: 15 were jaundiced, five had bilirubinuria, and one had pruritus. These complications occurred between four and 21 days after initial exposure to the drug. All patients recovered. Light and electron microscopic findings in liver biopsies of one of these patients were those of cholestasis without inflammation.
Antidepressants are among the most commonly prescribed drugs. Approximately 15% of all prescriptions written in Britain in recent years have been for psychotropic drugs (Dunlop, 1969) . Iprindole (Prondol) was introduced in the early 1960s and is a commonly used antidepressant which is claimed to have few side effects. The two patients to be reported in detail were both treated with iprindole for depression and developed a hepatic reaction; in one of these, liver biopsies were taken for light and electron microscopy. In addition, the clinical features in 19 other patients who had a hepatic reaction to iprindole are described.
Case Reports CASE 1 A 36-year-old woman had been unwell for two years. She has four children aged 15, 13, 8, and 6 she developed headache, fever, giddiness, and sweating, and three days later she noticed that her eyes were yellow and so stopped the iprindole. There had been no nausea, vomiting, or abdominal pain. The jaundice persisted and was associated with pruritus, dark urine, and pale stools. She had had no blood transfusions, no other drugs, and no contact with a jaundiced person. Alcohol intake had been minimal. Two months after starting iprindole she was admitted to hospital. Apart from jaundice the examination was unremarkable. The jaundice persisted and 12 weeks after the onset she was transferred to the Royal Free Hospital.
On examination she was jaundiced and there were scratch marks over the trunk. The liver edge was soft, slightly tender, and just palpable. Investigations showed a normal white blood cell count, eosinophil count, serum albumin and serum globulin. Hepatitis-associated antigen was not found in the serum. Results of liver function tests are shown in the Table. Itching was controlled using cholestyramine. She improved so that five months after starting the iprindole she was well and physical examination was normal. Increase in liver cell and nuclear size was noted particularly, and there were many binucleate cells. The appearances were compatible with druginduced cholestasis (Fig. 1) . The second biopsy, taken eight weeks later,
showed that cholestasis was still present but less. The liver-cell swelling and nuclear abnormalities were no longer seen. 
Electron Microscopy in Case 1
The ultrastructural changes in these two biopsies were those of cholestasis, as described by Steiner, Jezequel, Phillips, Miyai, and Arakawa (1965) and Popper and Schaffner (1970) . In the first biopsy the prominent ultrastructural feature was dilatation of bile canaliculi, and the presence in the lumens of osmiophilic deposits (Fig. 2) . These densities corresponded to bile pigment as seen by the light microscope. In the second biopsy, canalicular dilatation was no longer present but occasional dense osmiophilic deposits were seen which were thought to represent remaining intracellular bile.
Discussion
Iprindole is a drug belonging to the iminodibenzyl class, and acts on the presynaptic adrenergic nerve endings. It is unusual among antidepressant drugs in having an indole ring. During initial trials no evidence of hepatotoxicity was found (Hicks, 1965; Daneman, 1967) Young (1970) reported a 42-year-old woman who developed a generalized rash after taking five tablets of iprindole. This was associated with giant urticaria, dermatographia, and weal formation. She stopped taking the tablets and the rash cleared; on restarting, however, the rash recurred, she vomited bile-stained fluid, and felt ill. Her urine contained bilirubin. Serum bilirubin was 1.3 mg/100 ml, alkaline phosphatase 25 KA units, and GP transaminase 120 units. After finally stopping the tablets she recovered. Price and Collings-Wells (1970) reported two further patients. A 30-year-old housewife was treated with iprindole for depression. A week later she felt unwell and 10 days after starting therapy became jaundiced and developed discomfort in the right hypochondrium. Serum bilirubin was 1.1 mg/ 100 ml, alkaline phosphatase 10 KA units, and alanine transaminase 60 iu. The drug was stopped and she made a complete recovery. The second patient was a 49-year-old man. Ten days after starting therapy he became ill with fever and malaise. Three days later he was jaundiced. Serum bilirubin was 1. 8 mg/100 ml, alkaline phosphatase 19 KAunits and alanine transaminase 17 iu. Iprindole was discontinued and the patient gradually recovered. Harrison and Stanley (1970) reported four female patients, three of whom had an influenza-like illness. Two patients developed jaundice and the third had slightly elevated transaminase levels. They all recovered following withdrawal of the iprindole.
The course of the illness in the three patients already reported and the 21 patients in the present report show certain similarities. The patients usually became unwell one to two weeks after starting treatment, although in some symptoms began after a few days. Jaundice followed the systemic upset and many experienced an ache over the liver. Pruritus, if present, was not usually severe. When iprindole was stopped, all symptoms usually disappeared within a few days. Case 1 was an exception in that pruritus lasted for 10 weeks and was severe enough to warrant cholestyramine therapy.
The two cases reported in detail, and many of those reported to the Committee on Safety of Drugs, presented clinically a predominantly cholestatic picture with jaundice and pruritus, as well as slightly elevated alkaline phosphatase levels in cases 1 and 2. Evidence of hepatocellular damage was present in that aspartate transaminase levels were slightly elevated. The liver biopsy in case 1 showed cholestasis but no inflammation or necrosis. A generalized sensitivity reaction was suggested in the case reported by Young (1970) in that his patient had associated urticaria, dermatographia, and weal formation. However, in only two of all our cases was a rash present. One patient had an eosinophilia. It seems that iprindole may cause either a generalized hypersensitivity reaction with liver involvement or damage may be confined to the liver.
Jaundice has so far occurred in a very small minority of patients on the drug and in some the jaundice has been accompanied by other manifestations of hypersensitivity such as eosinophilia and dermatographia. When drugs of this type are tested in normal subjects no liver lesions are produced, and clinical trials must be extensive before a reaction is attributable with certainty to the drug. There is at present no evidence that iprindole can lead to chronic liver damage.
